The emergence of COVID-19 as a global pandemic: Understanding the epidemiology, immune response and potential therapeutic targets of SARS-CoV-2
An acute respiratory disease caused by a severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …
(SARS-CoV-2) that surfaced in China in late 2019, continues to spread rapidly across the …
Pulmonary fibrosis in COVID‐19 survivors: Predictive factors and risk reduction strategies
AS Ojo, SA Balogun, OT Williams… - Pulmonary medicine, 2020 - Wiley Online Library
Although pulmonary fibrosis can occur in the absence of a clear‐cut inciting agent, and
without a clinically clear initial acute inflammatory phase, it is more commonly associated …
without a clinically clear initial acute inflammatory phase, it is more commonly associated …
Antiviral treatment of COVID-19
Currently, there is not any specific effective antiviral treatment for COVID-19. Although most
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …
of the COVID-19 patients have mild or moderate courses, up to 5%-10% can have severe …
COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation
Coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …
coronavirus 2 (SARS-CoV-2) is a new pandemic infectious disease that originated in China …
Gastrointestinal manifestations in COVID-19
JC Kariyawasam, U Jayarajah, R Riza… - Transactions of The …, 2021 - academic.oup.com
Abstract Coronavirus disease 2019 (COVID-19), a respiratory viral infection, has affected
more than 78 million individuals worldwide as of the end of December 2020. Previous …
more than 78 million individuals worldwide as of the end of December 2020. Previous …
A review on drug repurposing applicable to COVID-19
S Dotolo, A Marabotti, A Facchiano… - Briefings in …, 2021 - academic.oup.com
Drug repurposing involves the identification of new applications for existing drugs at a lower
cost and in a shorter time. There are different computational drug-repurposing strategies and …
cost and in a shorter time. There are different computational drug-repurposing strategies and …
Adipose-derived mesenchymal stromal cells for the treatment of patients with severe SARS-CoV-2 pneumonia requiring mechanical ventilation. A proof of concept …
F Sánchez-Guijo, M García-Arranz… - …, 2020 - thelancet.com
Background Identification of effective treatments in severe cases of COVID-19 requiring
mechanical ventilation represents an unmet medical need. Our aim was to determine …
mechanical ventilation represents an unmet medical need. Our aim was to determine …
COVID‐19 and liver disease—what we know on 1st May 2020
I Garrido, R Liberal, G Macedo - Alimentary pharmacology & …, 2020 - Wiley Online Library
Background Severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), the
causative pathogen of coronavirus disease 2019 (COVID‐19), became a global threat to …
causative pathogen of coronavirus disease 2019 (COVID‐19), became a global threat to …
The SARS-coronavirus infection cycle: a survey of viral membrane proteins, their functional interactions and pathogenesis
NA Wong, MH Saier Jr - International journal of molecular sciences, 2021 - mdpi.com
Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel epidemic
strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus …
strain of Betacoronavirus that is responsible for the current viral pandemic, coronavirus …
COVID-19 pandemic: an overview of epidemiology, pathogenesis, diagnostics and potential vaccines and therapeutics
At the time of writing this review, severe acute respiratory coronavirus syndrome-2 (SARS-
CoV-2) has infected more than 2,355,853 patients and resulted in more than 164,656 deaths …
CoV-2) has infected more than 2,355,853 patients and resulted in more than 164,656 deaths …